Clinical Trial Update: ADME Study in Healthy Male Subjects With TA-8995 [Phase 1]

View source ↗

Summary

Phase 1 ADME study of TA-8995 in healthy male subjects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• TA-8995

Snippet

Sponsor: Xention Ltd | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED